Präklinische Evaluation eines neuartigen Therapieansatzes im malignen Melanom mittels F-18 FDG PET und Fluorescence Molecular Tomography (FMT)

Autor: MJ Evans, L Old, G Ritter, E Rosenfeld, AA Jungbluth, Lars Stelter, SM Larson, JS Bomalaski, P Zanzonico, T Ku

Publikováno v: RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 184

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e22cf078118153c2a437ed1274e78b52
https://doi.org/10.1055/s-0032-1311120

Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor

Autor: Mishima K, Tg, Johns, Rb, Luwor, Andrew Scott, Stockert E, Aa, Jungbluth, Xd, Ji, Suvarna P, Jr, Voland, Lj, Old, Hj, Huang, Wk, Cavenee

Publikováno v: Europe PubMed Central

A mutant epidermal growth factor receptor (variously called DeltaEGFR, de2-7 EGFR, or EGFRvIII) containing a deletion of 267 amino acids of the extracellular domain is frequently highly expressed in human malignant gliomas and has been reported for c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ebe7b825a7ff57a198d2cc069cb0cd15
http://europepmc.org/abstract/med/11454673

Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies.

Autor: Zaidi S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065.; Department of Medicine, Division of Solid Tumor Oncology, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Park J; Department of Biomedical Sciences, Korea University College of Medicine, Seoul 02841, Korea., Chan JM; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065.; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Roudier MP; Department of Urology, University of Washington, Seattle, WA 98195., Zhao JL; Astrazeneca Oncology R&D, New York, NY 10016., Gopalan A; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Wadosky KM; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263., Patel RA; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA 98195.; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA 98195., Sayar E; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA 98195.; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA 98195., Karthaus WR; Swiss Institute for Experimental Cancer Research, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland., Kates DH; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Chaudhary O; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Xu T; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Masilionis I; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Mazutis L; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Chaligné R; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Obradovic A; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032., Linkov I; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Barlas A; Molecular Cytology Core Facility, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York NY 10065., Jungbluth AA; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Rekhtman N; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Silber J; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Manova-Todorova K; Molecular Cytology Core Facility, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York NY 10065., Watson PA; Research Outreach and Compliance, Memorial Sloan Kettering Cancer Center, New York, NY 10065., True LD; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195., Morrissey C; Department of Urology, University of Washington, Seattle, WA 98195., Scher HI; Department of Medicine, Division of Solid Tumor Oncology, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Rathkopf DE; Department of Medicine, Division of Solid Tumor Oncology, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Morris MJ; Department of Medicine, Division of Solid Tumor Oncology, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Goodrich DW; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263., Choi J; Department of Biomedical Sciences, Korea University College of Medicine, Seoul 02841, Korea.; Department of Genetics, Yale University School of Medicine, New Haven, CT 06510., Nelson PS; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA 98195.; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA 98195., Haffner MC; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA 98195.; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA 98195.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195., Sawyers CL; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065.; HHMI, Memorial Sloan Kettering Cancer Center, New York, NY 10065.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Jul 09; Vol. 121 (28), pp. e2322203121. Date of Electronic Publication: 2024 Jul 05.

Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma.

Autor: Febres-Aldana CA; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Chang JC; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Jungbluth AA; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Adusumilli PS; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Bodd FM; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Frosina D; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Geronimo JA; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Hernandez E; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Irawan H; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Offin MD; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Rekhtman N; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Travis WD; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Vanderbilt C; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Zauderer MG; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Zhang Y; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Ladanyi M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Yang SR; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Sauter JL; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: sauterj@mskcc.org.

Publikováno v: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Mar; Vol. 37 (3), pp. 100420. Date of Electronic Publication: 2024 Jan 05.

Immunohistochemistry for PRAME in Dermatopathology.

Autor: Lezcano C; Pathologist, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Jungbluth AA; Pathologist, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; and., Busam KJ; Pathologist, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

Publikováno v: The American Journal of dermatopathology [Am J Dermatopathol] 2023 Nov 01; Vol. 45 (11), pp. 733-747.